Before revision:  The applicability of this approach is further demonstrated by applying it to both publically available microarray data from multiple sclerosis and diabetes patients as well as RNA sequencing data from breast cancer patients .
After revision:  We find that the method can uncover known results from genomics for all of the studied use cases, i.e. microarray data from multiple sclerosis and diabetes patients as well as RNA sequencing data from breast cancer patients .